Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

Current vaccine development includes optimization of antigen delivery to antigen presenting cells, such as dendritic cells (DC). Particulate systems have attracted increasing attention in the development of vaccine delivery systems. In the present study, we investigated DC uptake of model fluorescent polystyrene particles with a broad size range and variable surface properties. Localization of particles was investigated using confocal laser scanning microscopy and uptake was quantified by flow cytometry. Immature DC were generated from mononuclear cells isolated from human blood. The polystyrene particles interacted with the DC throughout the tested diameter range of 0.04-15 microm in a time- and concentration-dependent manner. The optimal particle diameter for fast and efficient acquisition by a substantial percentage of the DC was 0.5 microm and below. The surface of 1 and 0.1 microm polystyrene particles was covalently modified with different polyaminoacids/proteins, yielding particles with varying surface charge. Uptake of 1 microm particles was greatly enhanced when particles displayed a positive surface charge. In general, the present findings establish that particle diameters of 0.5 microm and below were optimal for DC uptake; however uptake of larger particles could be greatly enhanced by rendering the particle surface positive. Whether increased particle uptake is correlated with increased immune responses, remains to be established.

[1]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[2]  K. Rock,et al.  Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Steinman,et al.  The endocytic activity of dendritic cells , 1995, The Journal of experimental medicine.

[4]  K. Rock,et al.  Analysis of MHC class II presentation of particulate antigens of B lymphocytes. , 1996, Journal of immunology.

[5]  Sven Frokjaer,et al.  Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. , 2004, Vaccine.

[6]  J. Reece,et al.  Uptake of HIV and latex particles by fresh and cultured dendritic cells and monocytes , 2001, Immunology and cell biology.

[7]  C. Sousa,et al.  Phagocytosis of antigens by Langerhans cells in vitro , 1993, The Journal of experimental medicine.

[8]  L. Karlsson,et al.  Evaluation of phagocytic activity in human monocyte-derived dendritic cells. , 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[9]  H. Merkle,et al.  Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[10]  C Danieli,et al.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.

[11]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[12]  Hans P. Merkle,et al.  Phagocytosis and Phagosomal Fate of Surface-Modified Microparticles in Dendritic Cells and Macrophages , 2003, Pharmaceutical Research.

[13]  D. Niederwieser,et al.  Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. , 1996, Journal of immunological methods.

[14]  K. Rock,et al.  Fully mobilizing host defense: Building better vaccines , 1998, Nature Biotechnology.

[15]  Y Ikada,et al.  Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. , 1988, Biomaterials.

[16]  C. Harding,et al.  Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. , 1994, Journal of immunology.